Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says

Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says

Source: 
Fierce Pharma
snippet: 
A new interim analysis of presymptomatic spinal muscular atrophy patients treated with Biogen's Spinraza shows that the drug "has the potential to dramatically change the course" of the disease, according to a company executive.